ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Inari Medical, Inc. (NARI) shows an Average True Range (ATR) of 0.7 and an Enterprise Value of 2.21B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into NARI's underlying financial health and market activity.
Inari Medical, Inc. (NARI) technical indicators as of July 20, 2025: the SMA 20 is 0.28%, SMA 50 at 16.76%, and SMA 200 at 52.1%. The RSI 14 value is 79.6, suggesting its current momentum. These technical analysis signals help assess NARI's price trends and potential future movements.
Inari Medical, Inc. (NARI) stock performance overview as of July 20, 2025: The 52-week high is $79.99 (currently -0.02% below), and the 52-week low is $39.76 (currently 117.72% above). Over the past year, NARI's performance is N/A, compared to the S&P 500's 13.57% change.
According to market data, Inari Medical, Inc. (NARI) stock's recent performance metrics show that over the last month, NARI is 0.72%, with a Year-to-Date (YTD) performance of 56.65%. Over the past year, the stock has seen a N/A change. These figures summarize NARI's price movements across various periods, reflecting its historical returns.
According to current financial data, NARI stock's P/E (TTM) ratio is -59.40, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for NARI, including P/S (8.15), P/B (10.74), and P/FCF (2962.26), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.